TARGETING NEURONAL MIMICRY IN SMARCB1-DEFICIENT RENAL MEDULLARY CARCINOMA TREATMENT

$414,472FY2025Defense Health AgencyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators